Oct 20 (Reuters) - Horizon Pharma Plc:
* Horizon Pharma Plc announces pricing of private offering of senior notes
* Horizon Pharma Plc - priced their offering of $300 million aggregate principal amount of 8.750% senior notes due 2024 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.